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INTRODUCTION
Germ cells in the mouse fetal gonad are normally exposed to
molecular signals from the soma that trigger their differentiation
into sperm or oocytes (McLaren, 1983). In an ovary, germ cells
enter meiosis and commit to oogenesis around 13.5 days post
coitum (dpc) (Monk and McLaren, 1981; Speed, 1982). Recent
studies have demonstrated that retinoic acid (RA) present in the
ovary triggers germ cell entry into meiosis. In a testicular
environment, RA is prevented from inducing meiosis by the action
of the degradative p450 enzyme CYP26B1 (Bowles et al., 2006;
Koubova et al., 2006). Fibroblast growth factor 9 (FGF9) becomes
upregulated following the expression of SRY and SOX9 in the pre-
Sertoli cells of the developing testis. In addition to its important
functions in regulating somatic cell differentiation in the
developing testis (Colvin et al., 2001), FGF9 actively suppresses
entry into meiosis and stimulates commitment to spermatogenesis
in the germ cell lineage (Barrios et al., 2010; Bowles et al., 2010).
During normal development, testicular germ cells maintain
expression of pluripotency markers, including Oct4 and Sox2, for
about 2 days longer than XX germ cells, then cease dividing and
upregulate expression of male fate marker genes, including Nanos2
(Tsuda et al., 2003). Although the transition from pluripotency to
differentiation in the period 12.5-14.5 dpc is a crucial stage in the
development of male fetal germ cells, it is not known how this
transition is regulated at the molecular level.
Germ cells are often considered differentiated, uni-potential cells
because they usually generate only gametes. However, during some
phases of fetal life they are able to revert to functional pluripotency
both in vitro and in vivo. Germ cells isolated between 8.0 and 13.5
days post coitum (dpc) and cultured in a combination of stem cell
factor (SCF), leukemia inhibitory factor (LIF) and basic fibroblast
growth factor (bFGF, FGF2) can form ‘embryonic germ’ (EG) cell
colonies (Matsui et al., 1992; Resnick et al., 1992; Durcova-Hills
et al., 2006; Durcova-Hills and Surani, 2008; Matsui and Tokitake,
2009). EG cells closely resemble pluripotent embryonic stem (ES)
cells derived from the inner cell mass of blastocysts. Furthermore,
the fetal origins of testicular cancer hypothesis postulates that XY
germ cells that are not controlled appropriately during fetal life can
transform into carcinoma in situ (CIS), the pluripotent precursor
cells for testicular germ cell tumor (TGCT) (Skakkebæk et al.,
1987; Looijenga and Oosterhuis, 1999). In both of these situations,
molecular control mechanisms normally involved in suppression
of male germ cell pluripotency during fetal life appear to be
dysregulated.
Nodal, a member of the TGF morphogen family, is a key
regulator of early embryonic development known to establish the
anterior-posterior axis, specify mesoderm and endoderm during
gastrulation, pattern the nervous system and determine left-right
asymmetry (Shen, 2007). Nodal signals by binding to activin
receptors in the presence of the obligate co-receptor, Cripto (also
known as TDGF-1), leading to phosphorylation (activation) of
Smad2/3, which regulates transcription of target genes. Lefty1 and
Lefty2, also TGF molecules, repress the pathway in a dose-
dependent manner to limit the range of Nodal signaling. Nodal
upregulates its own expression, as well as that of Lefty1 and Lefty2
(Schier, 2003).
The Activin/Nodal class of TGFs has been linked to the
pluripotency of human and rabbit ES cells and pig, mouse and rat
epiblast stem cells (EpiSC) in vitro (James et al., 2005; Vallier et
al., 2005; Brons et al., 2007; Tesar et al., 2007; Honda et al., 2009;
Alberio et al., 2010). In vivo, loss of Nodal leads to loss of Oct4
expression in the epiblast, as well as premature differentiation of
epiblast and trophoblast cells (Brennan et al., 2001; Guzman-Ayala
et al., 2004; Camus et al., 2006; Mesnard et al., 2006). These
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SUMMARY
Germ cells, the embryonic precursors of sperm or oocytes, respond to molecular cues that regulate their sex-specific development
in the fetal gonads. In males in particular, the balance between continued proliferation and cell fate commitment is crucial: defects
in proliferation result in insufficient spermatogonial stem cells for fertility, but escape from commitment and prolonged pluripotency
can cause testicular germ cell tumors. However, the factors that regulate this balance remain unidentified. Here, we show that
signaling by the TGF morphogen Nodal and its co-receptor Cripto is active during a crucial window of male germ cell development.
The Nodal pathway is triggered when somatic signals, including FGF9, induce testicular germ cells to upregulate Cripto. Germ cells
of mutant mice with compromised Nodal signaling showed premature differentiation, reduced pluripotency marker expression and
a reduced ability to form embryonic germ (EG) cell colonies in vitro. Conversely, human testicular tumors showed upregulation of
NODAL and CRIPTO that was proportional to invasiveness and to the number of malignant cells. Thus, Nodal signaling provides a
molecular control mechanism that regulates male germ cell potency in normal development and testicular cancer.
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observations prompted us to investigate whether Nodal signaling
might play a later role in regulating pluripotency in a differentiated
cell lineage, the germ cells, during the organogenesis phase of fetal
development.
In this study, we show that Nodal signaling is active in XY but
not XX germ cells during mouse gonadal development. Genetic
suppression of Nodal signaling led to depressed pluripotency
marker expression and early XY germ cell differentiation. Levels
of Cripto expression and Nodal signaling correlated with
propensity of germ cells to de-differentiate and form EG cell
colonies in vitro. Finally, although neither NODAL nor CRIPTO are
normally expressed in adult human testes, we found aberrant
expression in both patient biopsies positive for CIS and the most
malignant TGCT subtypes. Our data indicate a previously
unknown role for this pathway in male germ cell development and
link dysregulation of this pathway with testis cancer.
MATERIALS AND METHODS
Mice
Protocols and use of animals in these experiments were approved by the
Animal Welfare Unit of the University of Queensland. The conditional
Nodal floxed allele (Nodalfl/fl) and the TNAPcre line were generated as
described (Lowe et al., 2001; Lomelí et al., 2000). Embryos were collected
from timed matings of the Nodalfl/fl, CD1 strain, the We/We mutant strain
(Buehr et al., 1993) and the Oct4PE:eGFP (OG2) strain (Szabó et al.,
2002), with noon of the day on which the mating plug was observed
designated 0.5 dpc.
Quantitative RT-PCR
Total RNA was extracted and cDNA generated from gonadal tissue,
cultured germ cells or isolated cell pools as described previously (Bowles
et al., 2010). Endogenous control primers used to normalize gene
expression levels were Tbp, Hprt, Sdha, Oct3/4 or Ddx4 (also known as
Mvh) for Taqman analyses, and Rn18s or Tbp for SYBR analyses; details
listed in supplementary material Table S1. Relative transcript abundance
was calculated using the 2–CT method. Error bars represent s.e.m.
calculated from the independent biological replicates and statistical
significance assessed using unpaired (two-tailed) Student’s t-test.
Germ cell isolation and culture
For pure germ cell isolation, gonadal tissue was collected from
Oct4PE:eGFP matings at 10.5 and 11.5 (unsexed) and 12.5, 13.5 and
14.5 dpc (sexed). Tissue was dissociated and germ cell (GFP+) and
somatic cell (GFP–) populations were isolated by fluorescence activated
cell sorting (FACS) using a FACSAria Cell Sorter (BD Biosciences). For
isolation of sub-populations expressing 6-integrin, gonadal tissue was
collected from CD1 embryos at 12.5 dpc as described previously
(Matsui and Tokitake, 2009) with minor modifications. After
dissociation, cells were incubated with FITC-conjugated anti-6-integrin
(CD49F; BD Biosciences, 555735) and/or PE-conjugated anti-SSEA-1
(stage-specific embryonic antigen-1; Bio-Scientific, FAB2155P). Germ
cells (anti-SSEA-1+) that were positive and negative for anti-6-integrin
were isolated by FACS using an Influx Cell Sorter (BD Biosciences) and
processed for RNA extraction. For analysis of germ cell subpopulations
expressing 6-integrin in 12.5 dpc Nodal mutant gonads, single gonad
pairs were processed as described above and analyzed using a LSRII
Analyzer (BD Biosciences). Statistical significance was determined
using a one-way ANOVA. Magnetic isolation of germ cells was
performed as described previously (Bowles et al., 2010).
Culture of germ cells and urogenital ridges was performed as described
previously (Bowles et al., 2010). Briefly, UGRs were cultured on filters
(Millipore, TMTP01300, 5 m) and germ cells were cultured sparsely
(~2000 cells per well) in feeder-free 12-well dishes. Additives to culture
were FGF9 (Sigma-Aldrich, 25 ng/ml), basic FGF (FGF2, #1104616,
Roche; 25 ng/ml), Nodal (recombinant Mouse, R&D Systems, 100 ng/ml)
and FGFR antagonist (SU5402, Calbiochem, 5 mM). Control cultures
included dilution vehicle.
Histological and immunofluorescence analysis
In vivo labeling with BrdU labeling reagent (Invitrogen, Cat# 00-0103)
was performed by injecting pregnant females intraperitoneally with 1.0
ml/100 g body weight of 1 BrdU. Embryos were harvested 2 hours after
BrdU injection, fixed in 4% paraformaldehyde in PBS overnight,
dehydrated and paraffin embedded. Immunofluorescence of deparaffinized
sections (7 m) was performed as described previously (Bowles et al.,
2010). Primary antibodies used were: anti-DDX4 (AB13840, Abcam;
1:1000), anti-E-Cadherin (#610182, BD; 1:200), anti-Cripto (AB19917,
Abcam;1:100), anti-phospho-SMAD2 (#3101, Cell Signaling; 1:300), anti-
SMAD2 (AB63576, Abcam; 1:100) and anti-BrdU (#555627, BD; 1:100).
Secondary antibodies (all from Molecular Probes; 1:200) were: goat anti-
rabbit Alexa Fluor 488, goat anti-rat Alexa Fluor 555 and goat anti-mouse
Alexa Fluor 594, and DAPI (D8417, Sigma-Aldrich; 1:2000). Sections
were examined by confocal microscopy using a Zeiss LSM-510 META
confocal microscope. The number of cells DDX4+/BrdU+ and
DDX4+/BrdU– (Fig. 3F) and DDX4+ cells (supplementary material Fig.
S3D) were counted manually in a minimum of 10 sections per gonad of
each genotype (Nodal+/+ and Nodalfl/fl; n4 and 4). Pair-wise comparisons
were analyzed using two-tailed Student’s t-test.
Western blotting
Western blot was performed by standard protocol on whole gonad-only
tissue. Two whole gonads (each Nodal genotype; Fig. 3) or four whole
gonads (wild-type analysis; Fig. 1 and supplementary material Fig. S1)
were used. Antibodies used were: anti-phospho-SMAD2 (#3101, Cell
Signaling, 1:1000), anti-TUBA1A (B-5-1-2, Sigma; 1:1000), anti-DDX4
(AB13840, Abcam; 1:1000), anti-NODAL (AB39242, Abcam; 1:200),
goat anti-mouse conjugated to horseradish peroxidase (HRP) (Sigma;
1:2000) and goat anti-rabbit conjugated to HRP (Vector Laboratories;
1:2000). Intensity of PSMAD2 bands was normalized against DDX4 and
TUBA1A (Fig. 3C) using Image Lab software (Bio-Rad Laboratories;
Version 4.0.1).
Derivation of EG cell colonies
EG derivation was performed as described (Durcova-Hills and Surani,
2008) with minor modifications. Briefly, 12.5 dpc Nodal+/+, Nodalfl/+ or
Nodalfl/fl single gonad-only pairs were dissociated and seeded onto one
well of a six-well culture plate (NUNC) containing 4105 cells/ml of
Mitomycin C-treated STO cells. Cells were incubated in PGC growth
media (Durcova-Hills and Surani, 2008), changed daily for 10 days. Wells
were stained for AP activity using the AP staining kit (Sigma, 86-R) as per
manufacturer’s instructions. The total number of AP-positive, densely
packed colonies was counted for each well. Statistical significance was
assessed by one-way ANOVA followed by a post-test for linear trend.
Analysis of human germ cell tumors
Use of the patient tissues is approved by an institutional review board
(MEC 02.981). Samples were used according to the ‘Code for Proper
Secondary Use of Human Tissue in The Netherlands’, from the Dutch
Federation of Medical Scientific Societies (FMWV, version 2002). Tissues
were collected as described (Looijenga et al., 2003), and tumors were
diagnosed according to WHO standards by an experienced pathologist (J.
Wolter Oosterhuis, Erasmus MC, Rotterdam, The Netherlands). The
testicular parenchyma samples investigated have been described previously
(Mosselman et al., 1996). qRT-PCR was performed on a 7900HT Fast
Real-Time PCR System (Applied Biosystems).
RESULTS
Nodal signaling is active in fetal XY germ cells
We have previously conducted a genome-wide microarray analysis
of gene expression in mouse fetal gonads (Holt et al., 2006).
Subsequent analysis showed that a number of genes associated
with the Nodal signaling pathway were expressed more highly in
XY compared with XX gonads at 12.0 dpc. Using quantitative
reverse transcriptase-PCR (qRT-PCR), we confirmed that Nodal,
Cripto, Lefty1 and Lefty2 are predominantly expressed in XY but
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not XX mouse fetal gonads at 12.5-15.5 dpc (Fig. 1A); in all cases,
expression was negligible at 11.5 dpc, peaked at 12.5 (Cripto) or
13.5 dpc (Nodal, Lefty1, Lefty2), and had mostly subsided by 14.5
dpc. We also investigated expression of Nodal and Cripto in
purified germ cell populations at 11.5-14.5 dpc (to account more
accurately for germ cell numbers) and detected peak expression at
13.5 and 12.5 dpc, respectively (supplementary material Fig.
S1A,B). Lack of expression of all four Nodal pathway genes in We
mutant gonads, which are devoid of germ cells, suggested that
these genes are either expressed by the germ cells of the fetal testis
or depend on the presence of germ cells (Fig. 1B). Expression of
all four genes began at least a day earlier than that of Nanos2,
which was previously the earliest known male-specific germ cell
marker and encodes a protein essential for male germ cell fate
commitment (Tsuda et al., 2003; Suzuki and Saga, 2008).
The obligate Nodal co-receptor Cripto was localized to the
surface of XY germ cells at 13.5 dpc, consistent with a role in
regulating Nodal signaling in the germline (Fig. 1C). Interstitial and
other somatic cells of the testis were negative for Cripto expression.
In addition to Cripto, the activin receptors ActRIIB (Acvr2b –
Mouse Genome Informatics), Alk4 or Alk7 are also required for
Nodal signaling (Shen, 2007). Acvr2b and Alk4 were detected in
both purified germ and somatic cells in XY and XX gonads at 13.5
dpc (Fig. 1D). Expression of Alk7 or the alternative Nodal co-
receptor Cryptic were not detected at appreciable levels at this time
(Fig. 1D). Quantitative RT-PCR analysis on purified germ cell and
somatic cell populations (supplementary material Fig. S1B)
confirmed male-specific Cripto expression restricted to germ cells.
Although some activin receptors are broadly expressed, the highly
cell-specific Cripto and Nodal expression (Fig. 1B-D;
supplementary material Fig. S1B) suggests that Nodal action is
limited to germ cells within the gonad.
Using western blot analysis, we could detect Nodal protein in
whole XY gonads from 13.5-15.5 dpc (supplementary material Fig.
S1C). To investigate whether Nodal signaling is actively engaged
in male germ cells, we tested for the presence of phospho-Smad2
(P-Smad2), an indicator of active activin/Nodal signaling. By
western blot, P-Smad2 was detected within fetal testes but not
ovaries at 12.5-15.5 dpc (Fig. 1E). Using immunofluorescence, we
found that P-Smad2 was largely restricted to the germ cells of 13.5
dpc testes (Fig. 1F). Given the restricted expression of Cripto, the
low level of P-Smad2 detected in somatic cells is likely to reflect
non-Nodal TGF signaling in these cells (Mendis et al., 2010).
Together, these results indicate that activin/Nodal signaling is
active in fetal XY germ cells, but not XX germ cells or gonadal
somatic cells, in the crucial 12.5-14.5 dpc period when their
proliferation is arrested and commitment to spermatogenic
differentiation is stimulated.
Cripto expression responds to Fgf9
Recently, we showed that the signaling molecule Fgf9, which is
highly expressed in the developing testis at 11.5 dpc, promotes
male germ cell fate (Bowles et al., 2010). In addition, XY, but not
XX, germ cells become dependent on Fgf9 by about 12.5 dpc
(DiNapoli et al., 2006). Given the upregulation of Cripto in XY
germ cells between 11.5 and 12.5 dpc (Fig. 1A) we reasoned that
its expression might be triggered by Fgf9. To test this hypothesis,
we carried out urogenital ridge (UGR) organ culture experiments:
Cripto expression was increased by Fgf9 (Fig. 2A) and decreased
in the presence of an FGF receptor antagonist (Fig. 2B). Nanos2, a
marker of male germ cell fate (Suzuki and Saga, 2008), was used
as a control in these experiments. In XY Fgf9-knockout mice,
expression of both Nodal and Cripto was low (data not shown), as
would be expected, as XY Fgf9-null gonads (including resident
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Fig. 1. The Nodal/Cripto signaling
pathway is active in mouse XY fetal
germ cells. (A,B)Nodal, Cripto, Lefty1 and
Lefty2 are expressed predominantly in XY
gonads at 12.5-15.5 dpc (A) and their
reduced expression in We/We germ cell-less
gonads (B) indicates expression by germ cells
(n3). Highest level of gene expression was
set as 1. (C)Nodal receptor Cripto (green) is
detected on the surface of 13.5 dpc XY
germ cells marked with E-cadherin (red);
DAPI marks nuclei (blue). (D)The activin
receptors Acvr2b and Alk4, but not Alk7, are
detectable in XX and XY germ cells (GC) and
gonadal somatic cells (SC) at 13.5 dpc.
Expression of Cripto is expressed by XY germ
cells, but the alternative receptor Cryptic is
not expressed a substantial level (n3).
(E)Phospho-Smad2 was detected by
western blot within wild-type XY gonad-only
samples at 12.5-15.5 dpc but was absent
from XX samples. Tuba1a was used as the
loading control. (F)Phospho-Smad2
(PSMAD2; red) was detected strongly in the
nucleus of 13.5 dpc XY germ cells marked
with E-cadherin (green). Nuclei are
counterstained with DAPI (blue). Expression
was normalized to Rn18s (A,B) and Tbp (D).
Scale bars: 100m.
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germ cells) undergo complete male-to-female sex reversal
(DiNapoli et al., 2006; Bowles et al., 2010).
We next confirmed that Fgf9 acts directly on isolated germ cells
to induce Cripto expression (Fig. 2C). Both XX and XY germ cells
behaved similarly under these conditions, suggesting that the
presence of Fgf9, rather than the chromosomal constitution of the
germ cells, ensures that Cripto is specifically induced in male germ
cells in vivo.
Although Fgf9 triggered Cripto expression, there was no
concomitant upregulation of Nodal expression in isolated 11.5 dpc
germ cells cultured for 18 hours (Fig. 2D). However, in intact UGR
cultures, which were started at 11.5 dpc and continued for 18 hours,
Fgf9 induced expression of both Cripto and Nodal (supplementary
material Fig. S2). We hypothesized that the differing observations
with respect to Nodal upregulation reflect the close clustering of
germ cells in the UGR system versus the sparse distribution of
germ cells in purified germ cell culture. We propose a mechanism
whereby FGF9 triggers Cripto expression in germ cells and that
this allows Nodal, which is initially present at low levels, to
feedback and upregulate its own expression in germ cells. Such a
mechanism is consistent with our observation that Cripto
expression peaks earlier than Nodal expression (Fig. 1A). In
support of this model, we found that when dispersed germ cells
were cultured in Fgf9 (to trigger Cripto expression) and exogenous
Nodal, expression of Nodal was induced (Fig. 2E,F).
Suppressed Nodal signaling leads to precocious
XY germ cell differentiation
In vitro, activin/Nodal signaling has been implicated in the
maintenance of the undifferentiated state in mammalian EpiSC and
ES cells (James et al., 2005; Vallier et al., 2005; Brons et al., 2007;
Tesar et al., 2007; Honda et al., 2009; Alberio et al., 2010). These
findings prompted us to investigate whether Nodal signaling might
play an analogous role during male germ cell development. To
address this question, we attempted conditional deletion of Nodal by
crossing Nodalfl/fl mice, in which Nodal exons 2 and 3 are flanked
by loxP recombination sites (Lowe et al., 2001), with the TNAPcre
strain of mice that expresses Cre recombinase in germ cells (Lomelí
et al., 2000). We were unable to obtain conditional mutant embryos,
perhaps owing to ectopic Cre recombinase expression in the TNAPcre
strain (Kehler et al., 2004; reviewed by Hammond and Matin, 2009)
and/or the reduced expression of Nodal (hypomorphism) in the
Nodalfl/fl strain prior to recombination (Lowe et al., 2001). For this
reason, we based all further studies on hypomorphic Nodalfl/fl
embryos, which displayed ~30% of wild-type testicular Nodal
expression (Fig. 3A) and survive to adulthood.
Immunofluorescence staining for the germ cell marker DDX4
was indistinguishable between Nodalfl/fl and wild-type gonads at
11.5 dpc (supplementary material Fig. S3A); this timepoint is prior
to germ cell expression of Nodal at 12.5 dpc (Fig. 1A), but after
the requirement for Nodal during gastrulation. The equivalent
DDX4 expression indicates that germ cell specification and
migration occur normally in Nodalfl/fl mutant embryos. DDX4
expression and germ cell numbers were also comparable between
genotypes at later stages (13.5, 14.5 and 17.5 dpc) of gonad
development (supplementary material Fig. S3A,B). Together, these
data indicate that there is no substantial loss of germ cells due to
decreased Nodal expression in Nodalfl/fl embryonic gonads. We
therefore questioned whether XY germ cells deficient in Nodal
were qualitatively abnormal.
To determine the effect of greatly reduced Nodal signaling in
XY germ cells, we first examined P-Smad2 expression in gonads
of the hypomorphic Nodalfl/fl mouse strain. Diminished levels of P-
Smad2 (but not SMAD2) in 14.5 dpc XY Nodalfl/fl gonads relative
to wild type (Fig. 3B,C; and data not shown) revealed that the
majority of Smad2 activation in the gonad was specifically
dependent on Nodal signaling, and was not part of a more
generalized response to other TGF signaling.
We next assayed markers of pluripotency and male germ cell
differentiation in Nodalfl/fl gonads. We detected reduced expression
of pluripotency markers Nanog, Sox2 and Oct3/4, and, conversely,
increased expression of male germ cell differentiation markers
Nanos2, p15 and Dnmt3l in Nodalfl/fl gonads, relative to wild type
at 14.5 dpc (Fig. 3D). Because this finding suggested early
differentiation of germ cells, we examined the total cohort of germ
cells 1 day earlier, when arrest was not yet complete and
differences in proliferation might be detected. BrdU incorporation
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Fig. 2. Cripto expression responds to Fgf9 in vitro. (A)In 11.5 dpc
XX and XY urogenital ridge cultures, Fgf9 induces Cripto expression;
Nanos2 is used as a control that responds to Fgf9. (B)A FGFR
antagonist suppresses Cripto expression in 11.5 dpc XY and XX
urogenital ridge cultures; Nanos2 is also suppressed. (C)Fgf9 induces
Cripto expression in XY and XX isolated 11.5 dpc germ cells cultured
for 18 hours. (D)Fgf9 treatment of isolated XY and XX 11.5 dpc germ
cells does not induce Nodal expression after 18 hours of culture.
(E)Fgf9 treatment, but not Nodal treatment, of isolated unsexed 11.5
dpc germ cells induces Cripto expression after 24 hours in culture.
(F)Treatment of 11.5 dpc unsexed germ cells with Fgf9 in addition to
exogenous Nodal induces Nodal expression after 24 hours. Expression
was normalized to Ddx4 (A-F) and the highest level of gene expression
was set as 100 in A and B. Statistical significance was assessed using
Student’s t-test (C,D) and one-way ANOVA with a Dunnett’s post-test
for multiple comparisons (E,F); error bars represent s.e.m. of four
independent experiments, each performed in duplicate (C-F) and s.d. of
technical replicates for one representative experiment (A,B); *P<0.05,
**P<0.005. ns, not significant.
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revealed that 27.8% of wild-type germ cells were proliferating at
13.5 dpc, in contrast to only 22.3% of Nodalfl/fl germ cells (Fig.
3E,F). This 5% difference in proliferating germ cell number,
though significant, was not manifest in total germ cell numbers at
13.5, 14.5 and 17.5 dpc (supplementary material Fig. S3B),
possibly owing to the sensitivity of our counting methods.
Last, because Fgf9 induces Nodal signaling via Cripto
expression (Fig. 2), and because it is also important for suppression
of XY germ cell meiosis (Bowles et al., 2010), we investigated the
meiosis marker Stra8 in our in vivo model of suppressed Nodal
signaling. However, in Nodalfl/fl mutant gonads, Stra8 expression
was not induced in XY germ cells at 14.5 dpc (Fig. 3D). Together,
our data suggest that when Nodal signaling is diminished, fetal XY
germ cells express markers of male fate commitment and cease
proliferation earlier than normal.
High Cripto expression characterizes a highly
pluripotent sub-population of germ cells
Previous studies have shown that mouse fetal germ cells are
heterogeneous with respect to cell-surface properties and ability to
generate pluripotent EG colonies in vitro. Matsui and Tokitake
(Matsui and Tokitake, 2009) flow-sorted mouse fetal germ cells
based on 6-integrin expression, and identified an 6-integrin-low
population of germ cells with 2.5-fold higher proclivity for forming
EG colonies. Because our in vivo findings linked Nodal signaling
with maintenance of pluripotency marker expression in germ cells,
we investigated whether expression of Nodal signaling components
characterized this sub-population of germ cells with the greatest
potential to undergo reprogramming to stem cells.
We flow-sorted 12.5 dpc germ cells (SSEA-1-positive) into 6-
integrin-negative and -positive pools (Fig. 4A; supplementary
material Fig. S4A,B), and assessed expression of Cripto, Nodal,
Lefty1, Lefty2 and the pluripotency markers Sox2, Oct3/4 and
Nanog in each by qRT-PCR. The 6-integrin-negative population
displayed higher expression of all markers than the 6-integrin-
positive population, with Cripto, Nodal and Lefty2 exhibiting the
greatest difference (2.08, 1.93 and 2.04 fold, respectively) of all
genes tested (Fig. 4B). These data indicate that, although Nodal
signaling genes appear to be expressed by all XY fetal germ cells
(Fig. 1C), highest expression of these characterizes the same
subpopulation of fetal testicular germ cells previously identified as
particularly pluripotent (Matsui and Tokitake, 2009).
Suppressed Nodal signaling reduces the efficiency
of EG cell derivation
We next investigated the effects of reduced Nodal signaling on EG
colony derivation. We cultured 12.5 dpc explanted testes from
wild-type, Nodal+/fl and Nodalfl/fl embryos under EG colony-
forming conditions; at this timepoint in Nodalfl/fl gonads, Nodal and
Cripto expression levels are ~20% and ~70% of wild-type levels
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Fig. 3. Compromised Nodal signaling leads to
premature differentiation and reduced pluripotency.
(A,B)Nodal mRNA (A) and phospho-Smad2 protein (B)
expression is reduced in XY Nodalfl/fl gonads at 14.5 dpc.
Ddx4 and Tuba1a are germ cell and total protein loading
controls, respectively; n3, 3 and 3 (A) and n2, 2 and 2 (B).
(C)Relative P-Smad2 expression from (B) normalized against
Tuba1a and Ddx4. (D)Pluripotency markers (Nanog, Sox2
and Oct3/4) are decreased and male differentiation markers
(Nanos2, p15 and Dnmt3l) are increased in 14.5 dpc male
Nodalfl/fl gonads; meiosis marker Stra8 was unchanged
between samples; female gonads were used as a control,
n3 and 3. (E)BrdU incorporation (green) was assessed in
germ cells (red; Ddx4) of 13.5 dpc Nodal+/+ and Nodalfl/fl XY
gonads, and was decreased in Nodalfl/fl germ cells compared
with wild-type controls. Scale bars: 100m. (F)27.8% of
wild-type germ cells were proliferating (BrdU positive) at
13.5 dpc, in contrast to only 22.3% in Nodalfl/fl gonads; n4
and 4. Expression was normalized to Ddx4 (A,D) and wild-
type gene expression was set as 1. Error bars represent
s.e.m. of three independent experiments, each performed in
triplicate; statistical significance was assessed using
Student’s t-test; *P<0.05, **P<0.005. Scale bars: 100m.
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respectively. Total germ cell numbers, indicated by Ddx4
expression, remained comparable with wild-type gonads
(supplementary material Fig. S4C), as did the ratio of 6-integrin-
negative to 6-integrin-positive germ cells assessed by flow
cytometry (supplementary material Fig. S4D). In the EG colony
derivation assay, each wild-type gonad pair generated 3.7±0.35
alkaline phosphatase-positive EG cell colonies (n7), whereas
1.0±0.33 EG cell colony arose from each Nodalfl/fl gonad pair (n6;
Fig. 4C). Thus, reduced Nodal signaling leads to reduced stem cell
potential of the total XY fetal germ cell population.
EG cell derivation requires the application of three factors:
FGF2, LIF and SCF (Matsui et al., 1992; Resnick et al., 1992;
Durcova-Hills et al., 2006; Durcova-Hills and Surani, 2008). We
found that FGF2, like FGF9, can induce Cripto expression in 10.5
and 12.5 dpc XX and XY germ cells (supplementary material Fig.
S4E), suggesting that its role during in vitro transformation of germ
cells to EG colonies may be to stimulate Cripto expression, thereby
enhancing pluripotency in those cells.
Nodal signaling components are overexpressed in
human testis cancers
CRIPTO was first identified from a human embryonal carcinoma
cell line, NTERA2 (Ciccodicola et al., 1989), and a later study
indicated that CRIPTO is expressed in some non-seminoma germ
cell tumors (Baldassarre et al., 1997). Most recently, heterogeneous
expression of CRIPTO within the human teratoma-derived
NTERA2 cell line identified CRIPTOHigh-expressing cells as those
having the greatest tumorigenic potential and most undifferentiated
phenotype (Watanabe et al., 2010). Our data identifying a function
for Cripto during normal XY fetal germ cell development led us to
speculate that CRIPTO expression may be maintained or re-
activated in carcinoma in situ (CIS), a tumor stem cell thought to
arise from fetal germ cells that fail to fully differentiate and are
retained in a dormant, pluripotent state in the adult testis
(Skakkebæk et al., 1987; Looijenga et al., 2003; de Jong et al.,
2008; Gillis et al., 2011). Currently, no CIS model exists in mice
(Oosterhuis and Looijenga, 2005; Looijenga et al., 2011),
precluding a test of this hypothesis in an experimental model
system. For this reason, we examined NODAL, CRIPTO and
LEFTY expression by qRT-PCR in a range of human testis biopsies
containing CIS cells. In support of our hypothesis, we found
highest expression of CRIPTO, NODAL and LEFTY1 in those
biopsies in which over 90% of tubules contained CIS (Fig. 5A-C).
The low levels of normalized gene expression reflect the fact that
CIS cells in these biopsies make up a very small proportion of total
cells.
All CIS ultimately progresses to either seminoma, a tumor type
composed of cells expressing fetal germ cell markers, or non-
seminoma, a diverse class of tumors including embryonal
carcinoma (EC), yolk sac tumor (YST), teratoma and
choriocarcinoma, that express a range of pluripotency markers
(Skakkebæk et al., 1987; Looijenga, 2009). Therefore, we next
tested whether Nodal pathway genes are upregulated in these
various testis cancers. We detected strong expression of CRIPTO
and NODAL in the invasive tumor types EC and YST, and varied
expression in mixed non-seminomas (mNS; Fig. 5D,E). Little or
no expression was associated with the benign tumors teratoma and
choriocarcinoma. LEFTY1 was overexpressed only in YST and
mNS (Fig. 5F); the absence of the NODAL inhibitor LEFTY1 in
EC may underlie its highly malignant phenotype (Postovit et al.,
2008). Within the mNS samples, which contain some differentiated
and some non-differentiated tissue, levels of CRIPTO, NODAL and
LEFTY1 expression were in direct proportion to the pluripotent EC
and YST cell content of each tumor (Fig. 5G-I). None of these
genes was overexpressed in seminomas or other types of germ cell
tumor (supplementary material Fig. S5A-C); the lack of
NODAL/CRIPTO expression may indicate that CIS cells reduce
their malignant behavior as they progress to seminoma. Together,
these results suggest that the Nodal pathway is activated in TGCTs
and is specifically associated with germ cell tumor pluripotency
and invasiveness, rather than being a cancer marker per se.
DISCUSSION
The Nodal signaling pathway is known to play important roles in
pattern formation during embryogenesis in a number of vertebrate
RESEARCH ARTICLE Development 139 (22)
Fig. 4. Nodal signaling determines germ cell pluripotency.
(A)FACS analysis of 12.5 dpc germ cells (Ssea1 positive), separated into
6-integrin-negative (2.66%; 6–) and -positive (2.13%; 6+)
populations. (B)Expression of Cripto, Nodal, Lefty1, Lefty2, Sox2,
Oct3/4 and Nanog in populations from A is higher in 6-integrin-
negative germ cells, n5. Expression was normalized to Tbp and gene
expression of the 6-integrin-positive population was set to 1.
Statistical significance was assessed using Student’s t-test; error bars
represent s.e.m.; *P<0.05, **P<0.005, ***P<0.0005; ns, not
significant. (C)EG colonies were derived at a significantly lower rate
from Nodalfl/fl than Nodal+/+ 12.5 dpc XY gonad pairs, based on alkaline
phosphatase staining (inset) after 10 days of culture; n7, 15 and 6.
Statistical significance was assessed using one-way ANOVA; bars
represent mean±s.e.m.; **P<0.005; ns, not significant.
D
E
V
E
LO
P
M
E
N
T
species. The present study expands the known developmental roles
of Nodal signaling by demonstrating that this pathway is transiently
active in male mouse fetal germ cells just prior to and during the
period of their sexual fate determination. We find that the germ
cells with the highest propensity to form pluripotent EG cell lines
in vitro are those that express the highest levels of Nodal signaling
genes. Hence, our studies suggest that the role of Nodal during
germ cell development is to regulate the timing of the transition
from proliferation to differentiation in the male germline during
fetal life. Finally, the observation that Nodal signaling is reactivated
ectopically in adult human TGCT provides a potential link between
fetal germ cell regulation and adult disease.
Investigating the regulation of Nodal signaling, we found that
Fgf9, which is expressed by the somatic cells of the testis, triggers
male germ cells to upregulate Cripto expression around 12.0-12.5
dpc, shortly after germ cell colonization of the developing testis
(supplementary material Fig. S6). This upregulation enables Nodal,
presumably present at low endogenous levels, to upregulate its own
expression and that of downstream targets Lefty1 and Lefty2,
peaking at 13.5 dpc. We have previously shown that Fgf9 acts to
make XY germ cells more resistant to entering meiosis, through an
unknown mechanism (Bowles et al., 2010). Hence, an obvious
hypothesis was that FGF9 acts on XY germ cells to trigger Nodal
signaling and thereby make those cells less likely to enter meiosis.
However, this hypothesis is not supported by our data: knockdown
of Nodal to 30% of normal levels had no effect on expression of
pre-meiotic gene Stra8 (Fig. 3D), although complete deletion of
Nodal is required to confirm this. Instead, our data suggest that the
role of Nodal signaling in XY germ cells is to extend the period of
pluripotency and delay the onset of differentiation. Following this
transient expression of Nodal pathway genes, TGF and activin
signaling evidently act to ensure correct G1/G0 arrest (Mendis et
al., 2010; Moreno et al., 2010). The expression of Cripto by XY
germ cells may make such cells temporarily resistant to the effect
of TGF and activin ligands, as has been suggested in other
systems (Gray et al., 2003; Gray et al., 2006). Diminished
expression of Cripto at these later time points, presumably owing
to a decrease in FGF9 signaling, should allow testicular germ cells
to become gradually responsive to other TGF factors. An
interesting possibility raised by our study is that FGF signaling
might play a similar role in other situations where Nodal signaling
has been implicated.
Our data indicate a role for Nodal signaling in regulating germ
cell potency in vivo. First, fetal germ cells from a genetic model of
reduced Nodal signaling are compromised in their ability to
generate pluripotent EG cell lines in culture. Second, the gonadal
germ cell fraction most competent to form EG cell lines in vitro
(Matsui and Tokitake, 2009) is that which expresses the highest
levels of Nodal signaling genes. These observations are consistent
with several in vitro studies linking TGF/activin/Nodal signaling
to cell pluripotency. James et al. (James et al., 2005) showed that
Smad2/3 is active in undifferentiated human ES cells, and that
chemical inhibition of activin receptor Alk4/5/7, using SB431542,
suppresses expression of the pluripotency marker Oct4 in mouse
blastocyst outgrowths during ES cell derivation in culture.
Similarly, SB431542 was found to reduce Smad2/3
phosphorylation and Oct4 expression in cultured rabbit ES cells
(Honda et al., 2009), and to promote differentiation/suppress
pluripotency markers in pig (Alberio et al., 2010) and mouse (Tesar
et al., 2007) epiblast stem cells. However, it is important to note
that these effects cannot be attributed specifically to Nodal
signaling, as SB431542 blocks signaling mediated by the entire
TGF/Activin/Nodal branch of the TGF superfamily.
One factor that is crucial for in vitro derivation of EG colonies
from fetal germ cells is FGF2. We found that FGF2, like FGF9,
was able to induce Cripto expression in fetal gonadal germ cells.
We propose that a role (if not the role) of FGF2 during in vitro
transformation of germ cells to EG colonies is to upregulate or
induce Cripto expression, thereby triggering Nodal signaling and
enhancing pluripotency potential in those cells (Fig. 6).
Interestingly, unlike LIF and SCF, FGF2 is required only for the
first 24 hours of EG derivation (Durcova-Hills et al., 2006); a
merely transient requirement for FGF2 could be explained if its
role is simply to trigger the upregulation of Cripto that facilitates
amplification of Nodal signaling.
It has recently been reported that Nodal expression in XY germ
cells functions to make them resistant to meiotic induction
(Souquet et al., 2012). By adding a chemical inhibitor (SB431542)
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Fig. 5. CRIPTO, NODAL and LEFTY1 are overexpressed in
human malignant testicular germ cell tumors. (A-C)Expression
of CRIPTO, NODAL and LEFTY1 increases with increasing
percentage of CIS-containing tubules in human adult testis
samples; n6, 4 and 6. (D-F)CRIPTO and NODAL expression is
upregulated in the pluripotent tumors embryonal carcinoma (EC),
mixed non-seminoma (mNS) and yolk sac tumor (YST). LEFTY1
expression is increased in YST and mNS but not EC, teratoma (TE)
or choriocarcinoma (CH); n6, 8, 2, 9 and 7. (G-I)Expression of
CRIPTO, NODAL and LEFTY1 increases in mNS tumors in proportion
to pluripotent EC and YST cell content. Linear regression lines are
shown, and coefficient of determination (R2) values are: 0.461
(CRIPTO), 0.994 (NODAL) and 0.619 (LEFTY1). Expression
normalized to TBP; data represent mean±s.e.m.
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of activin receptors Alk4, Alk5 and Alk7 to cultured mouse fetal
testes explanted at 11.5 dpc, Souquet et al. (Souquet et al., 2012)
found that some XY germ cells enter meiosis. Conversely, when
exogenous Nodal was added to cultured female gonads, a reduction
in the number of meiotic germ cells was observed. In our in vivo
model of suppressed Nodal signaling, Stra8 expression was not
induced in XY germ cells of Nodalfl/fl gonads at 14.5 dpc (Fig. 3D),
as might be expected if the role of Nodal was to suppress meiosis.
However, because Nodal expression is reduced, not ablated, in our
model, a role in suppressing meiosis can not be excluded.
Differences between endogenous and exogenous systems may
account for the different conclusions, therefore analysis of a
complete conditional null mutant will be required to determine
whether Nodal suppresses meiosis in vivo. A further discrepancy
between the two studies relates to the temporal profile of Nodal
signaling gene expression. Souquet et al. (Souquet et al., 2012)
reported that expression of Nodal, Cripto, Lefty1 and Lefty2 is
highest at 11.5 dpc and declines thereafter. Our experiments
indicated peak expression at 12.5 (Cripto) and 13.5 dpc (Nodal,
Lefty1 and Lefty2; Fig. 1A), consistent with human Nodal
expression and phospho-SMAD2 activation predominant from 13.5
dpc onwards. The disparity between our gene expression studies
can most likely be attributed to differences in normalizer genes
used. When normalizing against Ddx4 expression we observed the
same expression profile reported by Souquet et al. (Souquet et al.,
2012) (data not shown); however, because expression of Ddx4
increases in germ cells over time, it is considered an unsuitable
normalizer for dynamic studies of germ cell gene expression (van
den Bergen et al., 2009). Using a more appropriate normalizer,
Oct3/4, which is stable in XY germ cells over this timecourse (van
den Bergen et al., 2009), we observed peak expression in purified
germ cells at 12.5 and 13.5 dpc for Cripto and Nodal, respectively
(supplementary material Fig. S1B), as we also found when
analyzing gene expression in whole gonads (Fig. 1A).
Finally, we found a strong correlation between Nodal pathway
gene expression and malignant TGCTs. In previous studies,
expression of CRIPTO has been observed in a variety of
carcinomas, including mammary, pancreas, intestine and skin
cancer (Strizzi et al., 2005). In these situations, CRIPTO has
emerged as an oncogenic growth factor, controlling proliferation,
migration and survival (Bianco et al., 2005; Wechselberger et al.,
2005), but it remains unclear whether this involvement reflects the
role of Cripto in Wnt signaling, Src activation through glypican
binding or Nodal signaling (Bianco et al., 2010). Our data strongly
correlate CRIPTO expression with TGCT, and specifically
implicate dysregulation of the Nodal pathway in carcinogenesis, at
least in the context of TGCT.
TGCT is an unusual cancer in that it appears to be seeded during
fetal life, yet only manifests after puberty and during young
adulthood (Skakkebæk et al., 1987; Looijenga et al., 2011). It is
widely believed, based largely on chromatin modification studies,
that XY germ cells that do not undergo correct differentiation
during fetal development are able to survive as dormant pre-CIS
cells in the testis until, at puberty, they are reactivated to form CIS
cells that then progress to either seminoma or non-seminoma. Our
studies indicate that CRIPTO/NODAL expression is activated
ectopically in CIS cells and in the most pernicious forms of TGCT
in humans (Fig. 6). It is not yet clear whether CRIPTO expression
fails to be downregulated in some germ cells during fetal life, or
whether CRIPTO expression is re-initiated in some germ cells
during adult life. Our results strongly support a model whereby
TGCT is triggered by ectopic action of a program that normally
operates only during fetal germ cell development.
Our results have important implications for the etiology and
management of testicular cancer. Mechanistic studies of testis
cancer biology have been hampered by the lack of a mouse model
of CIS, and our results raise the possibility that sustained
expression of Cripto in transgenic mouse germ cells may provide
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Fig. 6. Model of Cripto expression during normal
germ cell development, EG colony derivation and
TGCT. During normal germ cell development, Cripto is
transiently expressed (red halo), coinciding with active
Nodal signaling, to maintain pluripotency. Under EG-
forming conditions, Cripto expression is induced in 10.5
dpc germ cells (normally Cripto negative) and is
increased above normal levels in 12.5 dpc germ cells
(normally Cripto positive). Under pathological conditions
(in the human), gonocytes that fail to undergo correct
spermatogenic differentiation but retain expression of
pluripotency markers develop into dormant, pre-
carcinoma in situ (pre-CIS) cells during infancy.
Following puberty, pre-CIS cells accumulate genomic
aberrations to become CIS cells, the precursor cell for
seminoma and non-seminoma germ cell tumors that
are positive for CRIPTO expression. Whether expression
of CRIPTO is retained or reactived during malignant
transformation is unknown. CRIPTO expression is lost
during CIS progression into seminoma. Conversely,
CRIPTO expression is retained during CIS progression
into embryonal carcinoma, yolk sac tumor (YST) and
mixed non-seminoma (mNS) tumors with high
percentages of embryonial carcinoma and YST.
Teratoma (TE) and choriocarcinoma (CH) are negative
for CRIPTO expression.
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such a model. Second, being a cell-surface protein, CRIPTO may
prove a tractable target for testicular cancer treatment, as it has
proven for various CRIPTO-positive solid tumors (Kelly et al.,
2011). Finally, detection of cleaved CRIPTO in human semen may
offer a non-invasive method of clinical diagnosis of a variety of
testis cancers, a possibility now under investigation.
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